Jump to content

Steven G Arless: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
→Notable awards: rem peacock word
→Career: remove puffery
Line 23: Line 23:
Arless took a position as the interim CEO of Resonant Medical from 2007-2008, while completing his Master’s in Business Administration at Concordia University.<ref>{{Cite news|url=http://www.newswire.ca/fr/news-releases/resonant-medical-announces-new-ceo-vp-strategic-marketing-and-chairman-of-the-board-of-directors-533802501.html|title=Resonant Medical announces new CEO, VP Strategic Marketing and Chairman of the Board of Directors|last=Sirois|first=Luc|date=May 23, 2007|work=Newswire (CISION)|access-date=October 23, 2017|archive-url=|archive-date=|dead-url=}}</ref> Resonant Medical went on to be sold to the Swedish medical technology company Elekta AB in 2010 for $30 million CAD.<ref>{{Cite news|url=https://www.itnonline.com/content/elekta-pays-30-million-cash-resonant-medical|title=Elekta Pays $30 Million in Cash for Resonant Medical|last=|first=|date=June 2, 2010|work=Imaging Technology News|access-date=October 23, 2017|archive-url=|archive-date=|dead-url=}}</ref>
Arless took a position as the interim CEO of Resonant Medical from 2007-2008, while completing his Master’s in Business Administration at Concordia University.<ref>{{Cite news|url=http://www.newswire.ca/fr/news-releases/resonant-medical-announces-new-ceo-vp-strategic-marketing-and-chairman-of-the-board-of-directors-533802501.html|title=Resonant Medical announces new CEO, VP Strategic Marketing and Chairman of the Board of Directors|last=Sirois|first=Luc|date=May 23, 2007|work=Newswire (CISION)|access-date=October 23, 2017|archive-url=|archive-date=|dead-url=}}</ref> Resonant Medical went on to be sold to the Swedish medical technology company Elekta AB in 2010 for $30 million CAD.<ref>{{Cite news|url=https://www.itnonline.com/content/elekta-pays-30-million-cash-resonant-medical|title=Elekta Pays $30 Million in Cash for Resonant Medical|last=|first=|date=June 2, 2010|work=Imaging Technology News|access-date=October 23, 2017|archive-url=|archive-date=|dead-url=}}</ref>


Arless relocated to [[Cleveland|Cleveland, Ohio]] in 2009 to become CEO of CardioInsight, another company marketing and advancing research in cardiovascular technology (also acquired by Medtronic Inc., in 2015)<ref name=":0" /><ref>{{Cite journal|last=Polishuk|first=Paul|date=November 2010|title=Opsens unveils Medical Device for the FFR Market|url=https://books.google.ca/books?id=vt58GbgY08sC&pg=PA7&lpg=PA7&dq=smith+%26+Nephew+steve+arless&source=bl&ots=Q05Ze-ETLa&sig=kZfnlxt_yBDHeEFufL2QlnOT5OM&hl=en&sa=X&ved=0ahUKEwiV3Z_wuPrWAhWMy4MKHWMKD2IQ6AEIUjAL#v=onepage&q=smith%20%26%20Nephew%20steve%20arless&f=false|journal=Military & Aerospace Fiber Optics|volume=4|pages=6–7|via=Google Books}}</ref> During his time at CardioInsight, Arless increased the company from 4 employees to over 20, and pioneered new electrocardiographic mapping technologies achieving commercial success.{{cn|date=February 2019}} Arless stepped down from his position at CardioInsight in 2012.<ref>{{Cite news|url=https://www.dicardiology.com/content/cardioinsight-completes-first-commercial-product-installation-its-ecvue-cardiac-mapping|title=CardioInsight Completes First Commercial Product Installation of its ECVUE Cardiac Mapping System|date=2012-02-24|work=Diagnostic and Interventional Cardiology {{!}} DAIC|access-date=2017-10-23|language=en}}</ref><ref>{{Cite web|url=http://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/cardiac-rhythm/cardioinsight-cardiac-mapping.html|title=CardioInsight Cardiac Mapping Procedure {{!}} Medtronic HCP|last=Medtronic|website=www.medtronic.com|language=en-US|access-date=2017-10-23}}</ref>
Arless relocated to [[Cleveland|Cleveland, Ohio]] in 2009 to become CEO of CardioInsight, another company marketing and advancing research in cardiovascular technology (also acquired by Medtronic Inc., in 2015)<ref name=":0" /><ref>{{Cite journal|last=Polishuk|first=Paul|date=November 2010|title=Opsens unveils Medical Device for the FFR Market|url=https://books.google.ca/books?id=vt58GbgY08sC&pg=PA7&lpg=PA7&dq=smith+%26+Nephew+steve+arless&source=bl&ots=Q05Ze-ETLa&sig=kZfnlxt_yBDHeEFufL2QlnOT5OM&hl=en&sa=X&ved=0ahUKEwiV3Z_wuPrWAhWMy4MKHWMKD2IQ6AEIUjAL#v=onepage&q=smith%20%26%20Nephew%20steve%20arless&f=false|journal=Military & Aerospace Fiber Optics|volume=4|pages=6–7|via=Google Books}}</ref> Arless stepped down from his position at CardioInsight in 2012.<ref>{{Cite news|url=https://www.dicardiology.com/content/cardioinsight-completes-first-commercial-product-installation-its-ecvue-cardiac-mapping|title=CardioInsight Completes First Commercial Product Installation of its ECVUE Cardiac Mapping System|date=2012-02-24|work=Diagnostic and Interventional Cardiology {{!}} DAIC|access-date=2017-10-23|language=en}}</ref><ref>{{Cite web|url=http://www.medtronic.com/us-en/healthcare-professionals/therapies-procedures/cardiac-rhythm/cardioinsight-cardiac-mapping.html|title=CardioInsight Cardiac Mapping Procedure {{!}} Medtronic HCP|last=Medtronic|website=www.medtronic.com|language=en-US|access-date=2017-10-23}}</ref>


Arless became a strategic [[angel investor]] in the medical technology sector, and co-founded medical device company, Soundbite Medical Solutions, using wire devices to treat occlusions caused by [[Coronary artery disease|coronary]] and [[peripheral artery disease]] with [[Shock wave|shockwaves]].<ref>{{Cite web|url=http://soundbitemedical.com/our-company/|title=Our Company – Soundbite medical|website=soundbitemedical.com|language=en-US|access-date=2017-10-23}}</ref> Arless recently stepped down from his role as CEO and will continue as Chairman of the Board at Soundbite.<ref>{{Cite web|url=http://soundbitemedical.com/soundbite-announces-new-ceo/|title=SoundBite announces new CEO – Soundbite medical|website=soundbitemedical.com|language=en-US|access-date=2017-10-23}}</ref>
Arless became a strategic [[angel investor]] in the medical technology sector, and co-founded medical device company, Soundbite Medical Solutions, using wire devices to treat occlusions caused by [[Coronary artery disease|coronary]] and [[peripheral artery disease]] with [[Shock wave|shockwaves]].<ref>{{Cite web|url=http://soundbitemedical.com/our-company/|title=Our Company – Soundbite medical|website=soundbitemedical.com|language=en-US|access-date=2017-10-23}}</ref> Arless recently stepped down from his role as CEO and will continue as Chairman of the Board at Soundbite.<ref>{{Cite web|url=http://soundbitemedical.com/soundbite-announces-new-ceo/|title=SoundBite announces new CEO – Soundbite medical|website=soundbitemedical.com|language=en-US|access-date=2017-10-23}}</ref>

Revision as of 06:16, 2 February 2019

Steven G Arless
Born (1949-07-23) July 23, 1949 (age 75)
Montréal, Québec, Canada
Alma materMcGill University (BSc 1971)
Concordia University (MBA 2008)
Occupation(s)Medical Technology Entrepreneur, Adjunct Professor
TitleProfessor of Practice, McGill University

Steven G Arless is a Canadian entrepreneur in the biomedical technology industry. He directed and developed several Medical Device companies treating cardiovascular diseases. He was the CEO of a number of companies, including CryoCath Technologies, Resonant Medical, and CardioInsight.[1][2] Arless is also an angel investor in medical technology.

Early life and education

Arless was born in Montréal in 1949. His father, an accountant, and his mother were immigrants to Canada from Lebanon.[3] Arless studied Chemistry and Engineering at McGill University in Montréal, Québec, graduating with a BSc. in 1971. After more than 30 years of entrepreneurial experience, Arless completed his MBA in at the John Molson School of Business at Concordia University in Montréal in 2008.[4]

Career

In 1971, Arless took a position with Smith & Nephew, a British medical equipment company, staying there for 17 years. His experience there cultivated a comprehensive knowledge of the medical device industry. He was CEO of North American operations from 1986-1990.[3]

Arless was instrumental in the development of CryoCath Technologies Inc. from a small medical technology start-up to an industry leader in cryotherapy technology, specifically catheter ablation used to treat heart arrhythmias. After Arless had worked at CryoCath for ten years (1996-2006) and had attracted sizable private and public investment, CryoCath was sold to Medtronic Inc. for $400 million CAD.[5]

Arless took a position as the interim CEO of Resonant Medical from 2007-2008, while completing his Master’s in Business Administration at Concordia University.[6] Resonant Medical went on to be sold to the Swedish medical technology company Elekta AB in 2010 for $30 million CAD.[7]

Arless relocated to Cleveland, Ohio in 2009 to become CEO of CardioInsight, another company marketing and advancing research in cardiovascular technology (also acquired by Medtronic Inc., in 2015)[2][8] Arless stepped down from his position at CardioInsight in 2012.[9][10]

Arless became a strategic angel investor in the medical technology sector, and co-founded medical device company, Soundbite Medical Solutions, using wire devices to treat occlusions caused by coronary and peripheral artery disease with shockwaves.[11] Arless recently stepped down from his role as CEO and will continue as Chairman of the Board at Soundbite.[12]

Areless is a Professor of Practice at Mcgill University.[4]

Awards

Arless was awarded the Ernst & Young Entrepreneur of the Year award in 2005 for Health Sciences.[13]

References

  1. ^ McEwen, Colin (January 20, 2011). "Q & A: Steve Arless brings stellar biomed reputation to Cleveland". Freshwater Cleveland. Retrieved October 23, 2017. {{cite web}}: Cite has empty unknown parameter: |dead-url= (help)
  2. ^ a b Mathre, Ryan (June 19, 2015). "Medtronic Announces Acquisition of CardioInsight Technologies, Developer of Non-Invasive Cardiac Mapping System". Medtronic Newsroom. Retrieved October 23, 2017. {{cite news}}: Cite has empty unknown parameter: |dead-url= (help)
  3. ^ a b Phillips, Scott (February 4, 2016). "Want to Be a Medical Device Entrepreneur?". MedTech Intelligence. Retrieved October 23, 2017. {{cite web}}: Cite has empty unknown parameter: |dead-url= (help)
  4. ^ a b "Steve Arless, one of Canada's leading medical device entrepreneurs joins McGill's Department of Surgery". McGill Faculty of Medicine Electronic Newsletter. December 16, 2016. Retrieved October 23, 2017. {{cite news}}: Cite has empty unknown parameter: |dead-url= (help)
  5. ^ Vanac, Mary (March 16, 2010). "CardioInsight CEO Steve Arless on the importance of being early". MassDevice. Retrieved October 23, 2017. {{cite web}}: Cite has empty unknown parameter: |dead-url= (help)
  6. ^ Sirois, Luc (May 23, 2007). "Resonant Medical announces new CEO, VP Strategic Marketing and Chairman of the Board of Directors". Newswire (CISION). Retrieved October 23, 2017. {{cite news}}: Cite has empty unknown parameter: |dead-url= (help)
  7. ^ "Elekta Pays $30 Million in Cash for Resonant Medical". Imaging Technology News. June 2, 2010. Retrieved October 23, 2017. {{cite news}}: Cite has empty unknown parameter: |dead-url= (help)
  8. ^ Polishuk, Paul (November 2010). "Opsens unveils Medical Device for the FFR Market". Military & Aerospace Fiber Optics. 4: 6–7 – via Google Books.
  9. ^ "CardioInsight Completes First Commercial Product Installation of its ECVUE Cardiac Mapping System". Diagnostic and Interventional Cardiology | DAIC. 2012-02-24. Retrieved 2017-10-23.
  10. ^ Medtronic. "CardioInsight Cardiac Mapping Procedure | Medtronic HCP". www.medtronic.com. Retrieved 2017-10-23.
  11. ^ "Our Company – Soundbite medical". soundbitemedical.com. Retrieved 2017-10-23.
  12. ^ "SoundBite announces new CEO – Soundbite medical". soundbitemedical.com. Retrieved 2017-10-23.
  13. ^ "Hall of Fame - EY Entrepreneur Of The Year". eoyhof.ey.com. Retrieved 2017-10-23.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Steven_G_Arless&oldid=881385957"